Hu SS - Search Results

1

SEMA3B-AS1 suppresses colorectal carcinoma progression by inhibiting Semaphorin 3B-dependent VEGF signaling pathway activation.

Wang YQ, Chen H, Xu S, Liao CR, Xu A, Han Y, Yang MH, Zhao L, Hu SS, Wang L, Li QY, Zhan LY, Ding YQ, Wang S. Wang YQ, et al. Among authors: hu ss. MedComm (2020). 2023 Sep 10;4(5):e365. doi: 10.1002/mco2.365. eCollection 2023 Oct. MedComm (2020). 2023. PMID: 37701532 Free PMC article.

2

[Expression of cAMP-dependent protein kinase inhibitor beta in colorectal carcinoma and its clinical significance].

Wang HW, Duan ZJ, Hu SS, Wang S. Wang HW, et al. Among authors: hu ss. Nan Fang Yi Ke Da Xue Xue Bao. 2017 Jun 20;37(6):744-749. doi: 10.3969/j.issn.1673-4254.2017.06.05. Nan Fang Yi Ke Da Xue Xue Bao. 2017. PMID: 28669946 Free PMC article. Chinese.

3

Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.

Yang MH, Zhao L, Wang L, Ou-Yang W, Hu SS, Li WL, Ai ML, Wang YQ, Han Y, Li TT, Ding YQ, Wang S. Yang MH, et al. Among authors: hu ss. Mol Cancer. 2019 Mar 1;18(1):31. doi: 10.1186/s12943-019-0955-9. Mol Cancer. 2019. PMID: 30823921 Free PMC article.

4

SATB2-AS1 Suppresses Colorectal Carcinoma Aggressiveness by Inhibiting SATB2-Dependent Snail Transcription and Epithelial-Mesenchymal Transition.

Wang YQ, Jiang DM, Hu SS, Zhao L, Wang L, Yang MH, Ai ML, Jiang HJ, Han Y, Ding YQ, Wang S. Wang YQ, et al. Among authors: hu ss. Cancer Res. 2019 Jul 15;79(14):3542-3556. doi: 10.1158/0008-5472.CAN-18-2900. Epub 2019 Mar 11. Cancer Res. 2019. PMID: 30858153

5

EHF promotes colorectal carcinoma progression by activating TGF-β1 transcription and canonical TGF-β signaling.

Wang L, Ai M, Nie M, Zhao L, Deng G, Hu S, Han Y, Zeng W, Wang Y, Yang M, Wang S. Wang L, et al. Cancer Sci. 2020 Jul;111(7):2310-2324. doi: 10.1111/cas.14444. Epub 2020 Jun 10. Cancer Sci. 2020. PMID: 32372436 Free PMC article.

6

SLC25A21 Suppresses Cell Growth in Bladder Cancer via an Oxidative Stress-Mediated Mechanism.

Wang Y, Gao J, Hu S, Zeng W, Yang H, Chen H, Wang S. Wang Y, et al. Front Oncol. 2021 Sep 9;11:682710. doi: 10.3389/fonc.2021.682710. eCollection 2021. Front Oncol. 2021. PMID: 34568013 Free PMC article.

7

SLC25A21 downregulation promotes KRAS-mutant colorectal cancer progression by increasing glutamine anaplerosis.

Hu SS, Han Y, Tan TY, Chen H, Gao JW, Wang L, Yang MH, Zhao L, Wang YQ, Ding YQ, Wang S. Hu SS, et al. JCI Insight. 2023 Nov 8;8(21):e167874. doi: 10.1172/jci.insight.167874. JCI Insight. 2023. PMID: 37937641 Free PMC article.

8

[Clinicopathological features and gene phenotypes of benign metastasizing leiomyoma].

Hu SS, Wang LL, Zhao H, Li GQ, Ji XB, Xin FJ, Wang JG. Hu SS, et al. Zhonghua Bing Li Xue Za Zhi. 2020 Jul 8;49(7):704-709. doi: 10.3760/cma.j.cn112151-20191030-00702. Zhonghua Bing Li Xue Za Zhi. 2020. PMID: 32610382 Chinese.

9

MAGI1 mediates tumor metastasis through c-Myb/miR-520h/MAGI1 signaling pathway in renal cell carcinoma.

Wang W, Yang Y, Chen X, Shao S, Hu S, Zhang T. Wang W, et al. Apoptosis. 2019 Dec;24(11-12):837-848. doi: 10.1007/s10495-019-01562-8. Apoptosis. 2019. PMID: 31352641

10

Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high-grade transformation from differentiated thyroid carcinoma.

Gu H, Wang J, Ran W, Li G, Hu S, Zhao H, Wang X, Wang J. Gu H, et al. J Pathol Clin Res. 2024 Mar;10(2):e356. doi: 10.1002/cjp2.356. J Pathol Clin Res. 2024. PMID: 38602501 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

541 results

Search Page

Filters